Skip to main content
Top
Published in: Medical Oncology 1/2009

01-03-2009 | CASE

Placental site trophoblastic tumor with multiple metastases and complete response to salvage BEP regimen: a case report and review of the literature

Authors: Selcuk Ayas, Ayse Gurbuz, Ates Karateke, Handan Cetiner

Published in: Medical Oncology | Issue 1/2009

Login to get access

Abstract

Placental site trophoblastic tumor is a rare form of gestational trophoblastic disease, derived from invasive implantation site (intermediate) trophoblastic cells. It is frequently resistant to chemotherapy. Patients with metastases, however, frequently have progressive disease and die despite surgery and multiagent chemotherapy. In this case, a 24-year-old woman was referred because of intermittent vaginal bleeding episodes for 5 months following delivery. Multiple metastases in lungs, liver, kidneys, breast, pancreas, and adrenal and thyroid glands were detected. Combination therapy including surgery and multiagent chemotherapy was planned. Hysterectomy and pelvic lymph node dissection were performed. All metastatic lesions disappeared with EMA-CO treatment. However four courses of BEP regimen, salvage therapy, was performed for plateauing hCG level. Surgery and multiagent chemotherapy seem mainstay of treatment of cases having multiple metastases of PSTTs.
Literature
1.
go back to reference Chang YL, Chang TC, Hsueh S, Huang KG, Wang PN, Liu HP, Soong YK. Prognostic factors and treatment for placental site trophoblastic tumor-report of 3 cases and analysis of 88 cases. Gynecol Oncol. 1999;73(2):216–22. doi:10.1006/gyno.1999.5344.PubMedCrossRef Chang YL, Chang TC, Hsueh S, Huang KG, Wang PN, Liu HP, Soong YK. Prognostic factors and treatment for placental site trophoblastic tumor-report of 3 cases and analysis of 88 cases. Gynecol Oncol. 1999;73(2):216–22. doi:10.​1006/​gyno.​1999.​5344.PubMedCrossRef
2.
go back to reference Seckl MJ, Newland ES. Management of gestational trophoblastic disease. In: Gershenson DM, McGuire WP, Gore M, Quinn MA, Thomas G, editors. Gynecologic cancer: controversies in management. Philadelphia: Churchill Livingstone/Elsevier Ltd.; 2004, p. 555–573. Seckl MJ, Newland ES. Management of gestational trophoblastic disease. In: Gershenson DM, McGuire WP, Gore M, Quinn MA, Thomas G, editors. Gynecologic cancer: controversies in management. Philadelphia: Churchill Livingstone/Elsevier Ltd.; 2004, p. 555–573.
3.
go back to reference Newlands ES, Mulholland PJ, Holden L, Seckl MJ, Rustin GJ. Etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EMA) chemotherapy for patients with high-risk gestational trophoblastic tumors refractory to EMA/cyclophosphamide and vincristine chemotherapy and patients presenting with metastatic placental site trophoblastic tumors. J Clin Oncol. 2000;18(4):854–9.PubMed Newlands ES, Mulholland PJ, Holden L, Seckl MJ, Rustin GJ. Etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EMA) chemotherapy for patients with high-risk gestational trophoblastic tumors refractory to EMA/cyclophosphamide and vincristine chemotherapy and patients presenting with metastatic placental site trophoblastic tumors. J Clin Oncol. 2000;18(4):854–9.PubMed
8.
go back to reference Creasman WT. Revision in classification by International federation of gynecology and obstetrics, letter to the editor Am J Obstet Gynecol. 1992;167:857–8.PubMed Creasman WT. Revision in classification by International federation of gynecology and obstetrics, letter to the editor Am J Obstet Gynecol. 1992;167:857–8.PubMed
10.
go back to reference Papadopoulos AJ, Foskett M, Seckl MJ, McNeish I, Paradinas FJ, Rees H, Newlands ES. Twenty-five years’ clinical experience with placental site trophoblastic tumors. J Reprod Med. 2002;47(6):460–4.PubMed Papadopoulos AJ, Foskett M, Seckl MJ, McNeish I, Paradinas FJ, Rees H, Newlands ES. Twenty-five years’ clinical experience with placental site trophoblastic tumors. J Reprod Med. 2002;47(6):460–4.PubMed
11.
go back to reference Nagai Y, Kamoi S, Matsuoka T, Hata A, Jobo T, Ogasawara T, Aoki Y, Ohira S, Okamoto T, Nakamoto T, Kanda K, Matsui H. Impact of p53 immunostaining in predicting advanced or recurrent placental site trophoblastic tumors: a study of 12 cases. Gynecol Oncol. 2007;106(3):446–52. Nagai Y, Kamoi S, Matsuoka T, Hata A, Jobo T, Ogasawara T, Aoki Y, Ohira S, Okamoto T, Nakamoto T, Kanda K, Matsui H. Impact of p53 immunostaining in predicting advanced or recurrent placental site trophoblastic tumors: a study of 12 cases. Gynecol Oncol. 2007;106(3):446–52.
12.
go back to reference Paradinas FJ, Elston CW. Gestational trophoblastic diseases. In: Fox H, Wells M, editors. Obstetrical and gynaecological pathology. 5th ed. London: Churchill Livingstone; 2003. p. 1359–1430. Paradinas FJ, Elston CW. Gestational trophoblastic diseases. In: Fox H, Wells M, editors. Obstetrical and gynaecological pathology. 5th ed. London: Churchill Livingstone; 2003. p. 1359–1430.
13.
go back to reference Raza A, Ahmad Z, Muzzaffar S. Placental site trophoblastic tumor (PSTT) with metastases to lungs and adrenal glands. J Coll Physicians Surg Pak. 2006;16(2):150–1.PubMed Raza A, Ahmad Z, Muzzaffar S. Placental site trophoblastic tumor (PSTT) with metastases to lungs and adrenal glands. J Coll Physicians Surg Pak. 2006;16(2):150–1.PubMed
14.
go back to reference Bruni R, Nigita G, Pagani Guazzugli Bonaiuti V, Petrocca S, Terenzi A. Adrenal metastatic placental site trophoblastic tumor. Case report. Chir Ital. 2003;55(2):257–60.PubMed Bruni R, Nigita G, Pagani Guazzugli Bonaiuti V, Petrocca S, Terenzi A. Adrenal metastatic placental site trophoblastic tumor. Case report. Chir Ital. 2003;55(2):257–60.PubMed
15.
go back to reference Li BZ, Zhu L, Duan W. Clinicopathologic study of tumors of intermediate trophoblasts. Zhonghua Bing Li Xue Za Zhi. 2006;35(12):722–6.PubMed Li BZ, Zhu L, Duan W. Clinicopathologic study of tumors of intermediate trophoblasts. Zhonghua Bing Li Xue Za Zhi. 2006;35(12):722–6.PubMed
17.
go back to reference Monclair T, Abeler VM, Kaern J, Walaas L, Zeller B, Hilstrom C. Placental site trophoblastic tumor (PSTT) in mother and child: first report of PSTT in infancy. Med Pediatr Oncol. 2002;38:187–91. doi:10.1002/mpo.1308.PubMedCrossRef Monclair T, Abeler VM, Kaern J, Walaas L, Zeller B, Hilstrom C. Placental site trophoblastic tumor (PSTT) in mother and child: first report of PSTT in infancy. Med Pediatr Oncol. 2002;38:187–91. doi:10.​1002/​mpo.​1308.PubMedCrossRef
18.
go back to reference Singer G, Kurman RJ, McMaster MT, Shih IeM. HLA-g immunoreactivity is specific for intermediate trophoblast in gestational trophoblastic disease and can serve as useful marker in differential diagnosis. Am J Surg Pathol. 2002;26(7):914–20. doi:10.1097/00000478-200207000-00010.PubMedCrossRef Singer G, Kurman RJ, McMaster MT, Shih IeM. HLA-g immunoreactivity is specific for intermediate trophoblast in gestational trophoblastic disease and can serve as useful marker in differential diagnosis. Am J Surg Pathol. 2002;26(7):914–20. doi:10.​1097/​00000478-200207000-00010.PubMedCrossRef
Metadata
Title
Placental site trophoblastic tumor with multiple metastases and complete response to salvage BEP regimen: a case report and review of the literature
Authors
Selcuk Ayas
Ayse Gurbuz
Ates Karateke
Handan Cetiner
Publication date
01-03-2009
Publisher
Humana Press Inc
Published in
Medical Oncology / Issue 1/2009
Print ISSN: 1357-0560
Electronic ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-008-9076-9

Other articles of this Issue 1/2009

Medical Oncology 1/2009 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.